Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
62 reviews, newest first
Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates
Cochraneheadline outcomes only
3 findings
Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants
Cochraneheadline outcomes only
11 findings
Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates
Cochraneheadline outcomes only
11 findings
Inhaled magnesium sulfate in the treatment of acute asthma
Cochraneheadline outcomes only
17 findings
Addition of anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma
Cochraneheadline outcomes only
18 findings
Stepping down the dose of inhaled corticosteroids for adults with asthma
Cochraneheadline outcomes only
14 findings
Long‐acting inhaled bronchodilators for cystic fibrosis
Cochraneheadline outcomes only
11 findings
Interventions to improve adherence to inhaled steroids for asthma
Cochraneheadline outcomes only
24 findings
Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults
Cochraneheadline outcomes only
7 findings
Combination inhaled steroid and long‐acting beta₂‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta₂‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Addition of long‐acting beta₂‐agonists to inhaled corticosteroids for chronic asthma in children
Cochraneheadline outcomes only
14 findings
Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
Cochraneheadline outcomes only
13 findings
Stopping long‐acting beta₂‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta₂‐agonists (LABA) for adults with asthma
Cochraneheadline outcomes only
7 findings
Inhaled hyperosmolar agents for bronchiectasis
Cochraneheadline outcomes only
14 findings
Addition to inhaled corticosteroids of long‐acting beta₂‐agonists versus anti‐leukotrienes for chronic asthma
Cochraneheadline outcomes only
7 findings
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Cochraneheadline outcomes only
6 findings
Inhaled corticosteroids in children with persistent asthma: effects on growth
Cochraneheadline outcomes only
3 findings
Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth
Cochraneheadline outcomes only
7 findings
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
14 findings
Inhaled anticholinergics and short‐acting beta₂‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital
Cochraneheadline outcomes only
6 findings
Combination inhaled corticosteroids and long‐acting beta₂‐agonists for children and adults with bronchiectasis
Cochraneheadline outcomes only
4 findings